PLB1003
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Unknown | INHIBITOR | ALK tyrosine kinase receptor inhibitor | no | 1 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Unknown | INHIBITOR | ALK tyrosine kinase receptor inhibitor | no | 1 | 0 |